408 related articles for article (PubMed ID: 25002509)
1. Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells.
Janzer A; German NJ; Gonzalez-Herrera KN; Asara JM; Haigis MC; Struhl K
Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10574-9. PubMed ID: 25002509
[TBL] [Abstract][Full Text] [Related]
2. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.
Orecchioni S; Reggiani F; Talarico G; Mancuso P; Calleri A; Gregato G; Labanca V; Noonan DM; Dallaglio K; Albini A; Bertolini F
Int J Cancer; 2015 Mar; 136(6):E534-44. PubMed ID: 25196138
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
[TBL] [Abstract][Full Text] [Related]
4. Serine deprivation enhances antineoplastic activity of biguanides.
Gravel SP; Hulea L; Toban N; Birman E; Blouin MJ; Zakikhani M; Zhao Y; Topisirovic I; St-Pierre J; Pollak M
Cancer Res; 2014 Dec; 74(24):7521-33. PubMed ID: 25377470
[TBL] [Abstract][Full Text] [Related]
5. Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport.
Velez J; Pan R; Lee JT; Enciso L; Suarez M; Duque JE; Jaramillo D; Lopez C; Morales L; Bornmann W; Konopleva M; Krystal G; Andreeff M; Samudio I
Oncotarget; 2016 Aug; 7(32):51435-51449. PubMed ID: 27283492
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics profiling of metformin-mediated metabolic reprogramming bypassing AMPKα.
Yan M; Qi H; Xia T; Zhao X; Wang W; Wang Z; Lu C; Ning Z; Chen H; Li T; Tekcham DS; Liu X; Liu J; Chen D; Liu X; Xu G; Piao HL
Metabolism; 2019 Feb; 91():18-29. PubMed ID: 30468782
[TBL] [Abstract][Full Text] [Related]
7. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
[TBL] [Abstract][Full Text] [Related]
8. The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL/T-LL cancer cells.
Rosilio C; Lounnas N; Nebout M; Imbert V; Hagenbeek T; Spits H; Asnafi V; Pontier-Bres R; Reverso J; Michiels JF; Sahra IB; Bost F; Peyron JF
Cancer Lett; 2013 Aug; 336(1):114-26. PubMed ID: 23612073
[TBL] [Abstract][Full Text] [Related]
9. Association of lactic acidosis with biguanide therapy.
Botha JL; Vinik AI; Jackson WP
S Afr Med J; 1977 Aug; 52(8):301-2. PubMed ID: 897932
[No Abstract] [Full Text] [Related]
10. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.
Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J
Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929
[TBL] [Abstract][Full Text] [Related]
11. [Effect of biguanide derivatives on blood lactic acid level in diabetics].
Lao B; Okniński W
Pol Arch Med Wewn; 1971 Dec; 47(6):675-8. PubMed ID: 5139041
[No Abstract] [Full Text] [Related]
12. Molecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinase.
Bridges HR; Sirviö VA; Agip AN; Hirst J
BMC Biol; 2016 Aug; 14():65. PubMed ID: 27506389
[TBL] [Abstract][Full Text] [Related]
13. The effects of metformin compared to the effects of phenformin on the lactate production and the metabolism of isolated parenchymal rat liver cell.
Jalling O; Olsen C
Acta Pharmacol Toxicol (Copenh); 1984 May; 54(5):327-32. PubMed ID: 6431751
[TBL] [Abstract][Full Text] [Related]
14. Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
Han YE; Hwang S; Kim JH; Byun JW; Yoon JS; Lee EJ
Thyroid; 2018 Apr; 28(4):528-536. PubMed ID: 29589999
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the effects of phenformin, buformin and metformin on blood lactate level].
Czyzyk A; Lao B; Bartosiewicz W; Szczepanik Z; Orłowska K
Pol Arch Med Wewn; 1978 Mar; 59(3):241-54. PubMed ID: 673874
[No Abstract] [Full Text] [Related]
16. Energy metabolism modulation by biguanides in comparison with rotenone in rat liver and heart.
Heinz S; Freyberger A; Lawrenz B; Schladt L; Schmuck G; Ellinger-Ziegelbauer H
Arch Toxicol; 2019 Sep; 93(9):2603-2615. PubMed ID: 31324951
[TBL] [Abstract][Full Text] [Related]
17. Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth.
Hirsch HA; Iliopoulos D; Struhl K
Proc Natl Acad Sci U S A; 2013 Jan; 110(3):972-7. PubMed ID: 23277563
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics.
Nattrass M; Todd PG; Hinks L; Lloyd B; Alberti KG
Diabetologia; 1977 Apr; 13(2):145-52. PubMed ID: 404205
[TBL] [Abstract][Full Text] [Related]
19. Effects of Biguanides on Growth and Glycolysis of Bladder and Colon Cancer Cells.
Lea MA; Kim H; desBORDES C
Anticancer Res; 2018 Sep; 38(9):5003-5011. PubMed ID: 30194144
[TBL] [Abstract][Full Text] [Related]
20. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion.
Iliopoulos D; Hirsch HA; Wang G; Struhl K
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1397-402. PubMed ID: 21220315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
